Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ENEMEEZ PLUS MINI ENEMA

docusate sodium and benzocaine
$0.3677per ML
OTC

Strength

20; 283 mg/5mL; mg/5mL

Manufacturer

Quest Products, LLC

NDC

17433987703

Classification

Brand

Dosage Form

LIQUID

Route

RECTAL

Last Updated

4/22/2026

Active Ingredients

BENZOCAINE; DOCUSATE SODIUM

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M007

On Market Since

6/15/2012

Pharmacological Classes

Allergens
Cell-mediated Immunity
Increased Histamine Release
Standardized Chemical Allergen

Price History

1W

0.0%

1M

+2.4%

3M

-1.8%

6M

-0.8%

1Y

-1.1%

3Y

N/A

5Y

N/A

All

+1.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MUCINEX INSTASOOTHE 7%-1% SPRY
Brand
72854026504•RB Health (US) LLC
$0.0544
per ML
FLEET GLYCERIN LIQUID SUPP
Brand
00132018582•C.B. Fleet Company, Inc.
$0.1287
per ML
CEPACOL SORE THROAT LOZENGE
Brand
63824071316•RB Health (US) LLC
$0.1484
per EA
CEPACOL SORE THROAT-COUGH LOZ
Brand
63824074416•RB Health (US) LLC
$0.1509
per EA
CEPACOL THROAT 15-2.6 MG LOZ
Brand
63824073216•RB Health (US) LLC
$0.1513
per EA
PREPARATION H CREAM
Brand
00573286820•Haleon US Holdings LLC
$0.1822
per GM
PREPARATION H CREAM
Brand
00573286810•Haleon US Holdings LLC
$0.2028
per GM
FLEET PEDIA-LAX SUPPOSITORIES
Brand
00132019012•C.B. Fleet Company, Inc.
$0.2086
per ML
REFRESH OPTIVE SENSITIVE DROPS
Brand
00023341660•Allergan, Inc.
$0.2943
per EA
REFRESH OPTIVE SENSITIVE DROPS
Brand
00023341630•Allergan, Inc.
$0.3408
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy